Sintx Stock Quote Today

<div class='circular--portrait' style='background:#8B008B;color: #ffffff;font-size:3em;padding-top: 38px;;'>AMD</div>
Equity ratings for Sintx are calculated daily based on the scoring framework. The performance scores are derived for the period starting the 26th of February 2020 and ending today, the 26th of May 2020. Click here to learn more.
Analyze Filter   Check how we calculate scores
Sintx cannot be verified against its exchange. It appears that Sintx is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Sintx Profile

Amedica Corporation, a biomaterial company, develops, manufactures, and commercializes a range of medical devices based on its silicon nitride technology platform in the United States, Europe, and South America. Amedica Corporation was founded in 1996 and is headquartered in Salt Lake City, Utah. Amedica Corp is traded on BATS Exchange in USA.. The public information regarding Sintx's current market price is not available at this time.
Legal NameSintx
Macroaxis Advice
Macroaxis buy hold or sell recommendation provided in the context of your current investment horizon and risk tolerance.
Horizon: 30 days (very short)Advice
Sintx [AMDDW] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Nano-Cap' category with current market capitalization of 664.86 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sintx's market, we take the total number of it shares issued and multiply it by the Sintx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Sintx has 3.02 M outstanding shares. The company has accumulated about 539 K in cash with (4.68 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.13.
Check Sintx Probability Of Bankruptcy

Sintx Stock Against Markets

Sintx cannot be verified against its exchange. It appears that Sintx is not available for investing at the moment. Please verify the symbol is currently traded on BATS Exchange. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refresh

Try Other Stock Suggestions

View Currently Related Equities

Please continue to Trending Equities. Please also try Piotroski F Score module to get piotroski f score based on binary analysis strategy of nine different fundamentals.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page